Becton, Dickinson and Co. | BDX - Debt


Becton, Dickinson and Co. reported $19.54B in Debt for its fiscal quarter ending in December of 2025.





Debt Change Date
Abbott USD 34.05B 20.19B Mar/2026
Agilent USD 3.35B 0 Dec/2025
Align Technology USD 114.45M 6.82M Dec/2025
AngioDynamics USD 6.3M 6.3M Feb/2025
Avanos Medical USD 129.1M 4.6M Dec/2025
Baxter International USD 9.78B 68M Dec/2025
Becton, Dickinson and Co. USD 19.54B 358M Dec/2025
Bio-Rad Laboratories USD 1.39B 9.2M Dec/2025
Boston Scientific USD 11.44B 610M Dec/2025
Cooper Companies USD 2.5B 5.6M Dec/2025
Danaher USD 18.48B 66M Mar/2026
Dentsply International USD 2.33B 137M Mar/2026
Dexcom USD 1.24B 900K Mar/2026
Edwards Lifesciences USD 600M 105.4M Mar/2026
Globus Medical USD 118.66M 687K Dec/2025
Insulet USD 949.2M 65.6M Dec/2025
Integra LifeSciences USD 2.04B 6.27M Mar/2026
Intuitive Surgical USD 0 0 Mar/2025
J&J USD 54.99B 7.05B Mar/2026
Medtronic USD 28.07B 1.03B Dec/2025
Solventum Corp USD 7.91B 97M Mar/2025
Stryker USD 14.22B 635M Mar/2026
Tandem Diabetes Care USD 444.48M 4.81M Dec/2025
Teleflex USD 2.73B 43.5M Dec/2025
Terumo JPY 159.87B 14.97B Sep/2025
Thermo Fisher Scientific USD 39.39B 3.7B Dec/2025
Zimmer Biomet Holdings USD 7.47B 48.1M Mar/2026